Declaring April 2 as "Liberation Day", US President Donald Trump announced the tariffs but has exempted certain sectors. India’s pharmaceutical sector has made a big win, temporarily avoiding the new levies.
The healthcare and pharma sector saw an overall 64 deals, valued at $2.8 billion in Q3 of 2024, marking the sector's highest quarterly volumes in three years, according to a report on Tuesday.
As revealed in its latest Annual Trends Report 2024, AuthBridge highlighted significant discrepancies across various sectors.
Indian IT, Biotech and pharma industries will not be impacted due to Donald Trump's policies as the US is expected…
